To examine: Whether the statement “A wide variety of dietary supplements, ranging from evening primrose oil to St. John’s Wort has been found to effectively and safely treat the symptoms of PMS” is true or false. Introduction: Premenstrual syndrome (PMS) is a physiological problem that begins after ovulation and ends with menstrual bleeding (luteal phase). It is usually characterized by psychological changes such as depression, irritability, anxiety, social withdrawal, and physical changes such as tender breasts, abdominal bloating, swelling, and headache that can disrupt daily life.

Question

Want to see the full answer?

Answer 1

Question

Chapter 3, Problem 2RQ

Summary Introduction

To examine: Whether the statement “A wide variety of dietary supplements, ranging from evening primrose oil to St. John’s Wort has been found to effectively and safely treat the symptoms of PMS” is true or false.

Introduction: Premenstrual syndrome (PMS) is a physiological problem that begins after ovulation and ends with menstrual bleeding (luteal phase). It is usually characterized by psychological changes such as depression, irritability, anxiety, social withdrawal, and physical changes such as tender breasts, abdominal bloating, swelling, and headache that can disrupt daily life.

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Students have asked these similar questions

Determination is irreversible. True False

Please put this in layman terms for me. I don't understand what it is saying. The clinical trial is increaseing diabetecs medicine Results: Among 41,233 patients, 33.5% and 45.3% had treatment intensified within 6 and 12 months, respectively. This first intensification was most often with increased index medication dosage (78%), least often with insulin (<1%). HbA1c% was strongly associated with intensification (adjusted hazard ratios [HR] 1.59, 3.62, 4.44, and 5.52 for HbA1c 6.5% to <7%, 7% to <7.5%, 7.5 to <8%, and ≥8%, respectively, all P < 0.001, compared with HbA1c < 6.5%). In patients initially on monotherapy, age modified the HbA1c effect: at HbA1c < 7%, the HR differed little between middle-aged and older patients; at HbA1c ≥ 7%, the HR decreased with older age (e.g., age 40-49 years and HbA1c ≥ 8%: HR 8.14; age ≥ 80 years and HbA1c ≥ 8%: HR 4.44; compared with age ≥ 80 years and HbA1c < 6.5%). Within 1 year, 84.3% achieved HbA1c < 8%; 65.1%…

Match the sample to the patient. Establish if the patients are diabetics. Do you think the patients have good or poor glycaemic control? Are there any other signs of complications. Patient 1. A 54 year-old male with a history of Type 1 Diabetes requiring insulin administered by pumpwith good A1c levels and a long history of compliance. Patient 2. A 24-year old sexually active male attending an insurance physical with no symptoms and noknown pre-existing conditions. Patient 3. A 22-year old female patient with a history of Type 1 Diabetes, a tendency to forget to takeher insulin and a history of hospitalisations due to diabetic-associated complications. Patient 4. A 24-year old sexually active female with a recent history of amenorrhea complaining ofnausea and increased irritability